• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR SUPERA SELF-EXPANDING STENT SYSTEM; SELF EXPANDING PERIPHERAL STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR SUPERA SELF-EXPANDING STENT SYSTEM; SELF EXPANDING PERIPHERAL STENT SYSTEM Back to Search Results
Catalog Number 42055150-120
Device Problems Difficult to Remove (1528); Material Separation (1562); Migration (4003)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 02/08/2023
Event Type  Injury  
Manufacturer Narrative
The device was returned.Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.
 
Event Description
It was reported that the procedure was to treat a moderately calcified, 50% stenosed lesion in the distal superficial femoral artery (dsfa).The lesion was pre-dilatated with non-abbott balloons, and a 5.5x150mm supera peripheral self-expanding stent system (sess) was advanced.The stent was implanted without issue.Upon removal of the sess from the anatomy, resistance was met and the nose cone separated and remained in the guiding sheath.The guiding sheath was attempted to be removed with the nose cone; however, upon passing through the iliac artery, the nose cone dislodged from the guiding sheath.A snare was used to capture the nose cone.During removal of the snared nose cone, the implanted stent was removed as well as the nose cone was attached to the implanted stent.A new 5.5x150mm supera stent was implanted to complete the procedure.No additional information was provided.
 
Manufacturer Narrative
The device was returned for analysis.The reported tip material separation was able to be confirmed.The reported difficult to remove and the reported stent migration was unable to be replicated in a testing environment as they were based on operational circumstances.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history did not indicate a lot specific quality issue.A cine was received and reviewed by an abbott vascular clinical specialist.In conclusion: the incident report states that during the deployment of a 5.5 x 150 mm supera self-expanding stent the nose cone of the stent delivery system separated, requiring retrieval via snaring.The provided media (cine video) displays a supera stent in the process of deployment in a calcified femoral artery.During stent deployment the nose cone is initially moving as expected but then becomes stuck within the stent while the stent delivery system continues to retract.The media confirms the incident report description that the nose cone separated from the stent delivery catheter.No probable cause for the nose cone separation can be determined from the provided media.As there was no damage noted to the device during the inspection prior to use, the investigation determined the reported difficulties appear to be related to circumstances of the procedure as it is likely that during system removal interaction of the deployed stent with the nose cone inadvertently resulted in the reported difficult to remove.Manipulation of the device ultimately resulted in the reported tip separation/noted tip and inner member separations.The treatment appears to be related to the operational context of the procedure as reportedly a snare was used to capture the nose cone and thus inadvertently resulted in the reported stent migration as the nose cone as was attached to the implanted stent during removal.There is no indication of a product quality issue with respect to manufacture, design or labeling.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SUPERA SELF-EXPANDING STENT SYSTEM
Type of Device
SELF EXPANDING PERIPHERAL STENT SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 2024168
26531 ynez road
temecula CA 92591 4628
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key16503933
MDR Text Key310893816
Report Number2024168-2023-02378
Device Sequence Number1
Product Code NIP
Combination Product (y/n)N
Reporter Country CodeNL
PMA/PMN Number
P120020
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative,Distributor
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 04/24/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number42055150-120
Device Lot Number2090661
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer03/03/2023
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 02/13/2023
Initial Date FDA Received03/08/2023
Supplement Dates Manufacturer Received03/30/2023
Supplement Dates FDA Received04/24/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured09/06/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
5 - 200 MM STANDARD BALLOON.; 5 - 200 MM ULTRASCORE BALLOON.; 6 F SHEATH.; 9 F SHEATH.
Patient Outcome(s) Required Intervention;
-
-